

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 5.48580013 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.70769080 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.67574012 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67574012 |
| 5 | tachykinin receptor signaling pathway (GO:0007217) | 4.56820270 |
| 6 | neural tube formation (GO:0001841) | 4.43648048 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.27194052 |
| 8 | establishment of protein localization to Golgi (GO:0072600) | 4.22442314 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.18054920 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.18054920 |
| 11 | protein targeting to Golgi (GO:0000042) | 4.04191377 |
| 12 | nucleobase catabolic process (GO:0046113) | 4.01370194 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.00584260 |
| 14 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.91063080 |
| 15 | dentate gyrus development (GO:0021542) | 3.89269968 |
| 16 | protein carboxylation (GO:0018214) | 3.87415712 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.87415712 |
| 18 | protein polyglutamylation (GO:0018095) | 3.79707873 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.70017209 |
| 20 | tyrosine metabolic process (GO:0006570) | 3.67125718 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65698418 |
| 22 | complement activation, alternative pathway (GO:0006957) | 3.64419457 |
| 23 | epithelial cilium movement (GO:0003351) | 3.61333894 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60474452 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60474452 |
| 26 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.60286316 |
| 27 | bile acid biosynthetic process (GO:0006699) | 3.59949180 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53079172 |
| 29 | positive regulation of neurological system process (GO:0031646) | 3.53072396 |
| 30 | regulation of bile acid biosynthetic process (GO:0070857) | 3.50916274 |
| 31 | ethanol oxidation (GO:0006069) | 3.50216322 |
| 32 | regulation of cilium movement (GO:0003352) | 3.43943782 |
| 33 | regulation of protein activation cascade (GO:2000257) | 3.40492613 |
| 34 | intraciliary transport (GO:0042073) | 3.40432160 |
| 35 | head development (GO:0060322) | 3.35461694 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.34158564 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.34158564 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 3.34158564 |
| 39 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.34002266 |
| 40 | regulation of complement activation (GO:0030449) | 3.27250416 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.25048140 |
| 42 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.23504211 |
| 43 | urea cycle (GO:0000050) | 3.23038574 |
| 44 | urea metabolic process (GO:0019627) | 3.23038574 |
| 45 | valine metabolic process (GO:0006573) | 3.22507705 |
| 46 | olfactory bulb development (GO:0021772) | 3.20440342 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16836481 |
| 48 | axoneme assembly (GO:0035082) | 3.16636523 |
| 49 | cilium movement (GO:0003341) | 3.15830470 |
| 50 | acrosome reaction (GO:0007340) | 3.14788446 |
| 51 | negative regulation of neurological system process (GO:0031645) | 3.14723010 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14656588 |
| 53 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.14174920 |
| 54 | regulation of sarcomere organization (GO:0060297) | 3.13023966 |
| 55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11665607 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.07231968 |
| 57 | bile acid metabolic process (GO:0008206) | 3.05794290 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.04799029 |
| 59 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.04665446 |
| 60 | presynaptic membrane organization (GO:0097090) | 3.04428780 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 3.04330196 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.02857551 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02165633 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.01773007 |
| 65 | cilium organization (GO:0044782) | 3.01739619 |
| 66 | cilium assembly (GO:0042384) | 3.01261231 |
| 67 | protein localization to Golgi apparatus (GO:0034067) | 3.00377128 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 2.99277009 |
| 69 | Golgi to endosome transport (GO:0006895) | 2.98452556 |
| 70 | cilium morphogenesis (GO:0060271) | 2.98068371 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96057200 |
| 72 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.95691969 |
| 73 | drug transmembrane transport (GO:0006855) | 2.95319174 |
| 74 | histone mRNA catabolic process (GO:0071044) | 2.93544531 |
| 75 | glyoxylate metabolic process (GO:0046487) | 2.93280422 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 2.92481244 |
| 77 | kynurenine metabolic process (GO:0070189) | 2.90961535 |
| 78 | blood coagulation, intrinsic pathway (GO:0007597) | 2.90769103 |
| 79 | cellular response to ethanol (GO:0071361) | 2.89501493 |
| 80 | sulfur amino acid catabolic process (GO:0000098) | 2.88761067 |
| 81 | protein K11-linked deubiquitination (GO:0035871) | 2.88377912 |
| 82 | cysteine metabolic process (GO:0006534) | 2.86661045 |
| 83 | positive regulation of respiratory burst (GO:0060267) | 2.86649417 |
| 84 | definitive hemopoiesis (GO:0060216) | 2.86285503 |
| 85 | acrosome assembly (GO:0001675) | 2.86025151 |
| 86 | macroautophagy (GO:0016236) | 2.84902325 |
| 87 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83503742 |
| 88 | opsonization (GO:0008228) | 2.80814660 |
| 89 | regulation of transmission of nerve impulse (GO:0051969) | 2.78743265 |
| 90 | aromatic amino acid family metabolic process (GO:0009072) | 2.78717105 |
| 91 | protein targeting to lysosome (GO:0006622) | 2.77997962 |
| 92 | establishment of protein localization to vacuole (GO:0072666) | 2.77997962 |
| 93 | protein targeting to vacuole (GO:0006623) | 2.77997962 |
| 94 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.77267850 |
| 95 | phospholipid efflux (GO:0033700) | 2.76176834 |
| 96 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.74841551 |
| 97 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.74841551 |
| 98 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.74841551 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.73850376 |
| 100 | prenylation (GO:0097354) | 2.72938279 |
| 101 | protein prenylation (GO:0018342) | 2.72938279 |
| 102 | protein-lipid complex assembly (GO:0065005) | 2.72025545 |
| 103 | plasma lipoprotein particle remodeling (GO:0034369) | 2.71983473 |
| 104 | protein-lipid complex remodeling (GO:0034368) | 2.71983473 |
| 105 | macromolecular complex remodeling (GO:0034367) | 2.71983473 |
| 106 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.71583820 |
| 107 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.70894762 |
| 108 | protein localization to cilium (GO:0061512) | 2.70161288 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 2.70014821 |
| 110 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.68558644 |
| 111 | amino-acid betaine metabolic process (GO:0006577) | 2.67414877 |
| 112 | positive regulation of granulocyte differentiation (GO:0030854) | 2.67360751 |
| 113 | cholesterol efflux (GO:0033344) | 2.67086882 |
| 114 | phospholipid homeostasis (GO:0055091) | 2.66886654 |
| 115 | cell wall macromolecule catabolic process (GO:0016998) | 2.66469359 |
| 116 | regulation of cholesterol esterification (GO:0010872) | 2.66120711 |
| 117 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.65226469 |
| 118 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.64960748 |
| 119 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.64960748 |
| 120 | positive regulation of glycolytic process (GO:0045821) | 2.64840599 |
| 121 | triglyceride homeostasis (GO:0070328) | 2.64646760 |
| 122 | acylglycerol homeostasis (GO:0055090) | 2.64646760 |
| 123 | forebrain neuron differentiation (GO:0021879) | 2.63574227 |
| 124 | behavioral response to ethanol (GO:0048149) | 2.63333904 |
| 125 | photoreceptor cell maintenance (GO:0045494) | 2.63317130 |
| 126 | polyol catabolic process (GO:0046174) | 2.62856202 |
| 127 | very long-chain fatty acid metabolic process (GO:0000038) | 2.62394302 |
| 128 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.61537582 |
| 129 | regulation of triglyceride catabolic process (GO:0010896) | 2.61135245 |
| 130 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.60769546 |
| 131 | negative regulation of lipase activity (GO:0060192) | 2.60323372 |
| 132 | snRNA transcription (GO:0009301) | 2.60175528 |
| 133 | protein activation cascade (GO:0072376) | 2.59985342 |
| 134 | bile acid and bile salt transport (GO:0015721) | 2.58522849 |
| 135 | cerebral cortex cell migration (GO:0021795) | 2.58192044 |
| 136 | myelin assembly (GO:0032288) | 2.58169689 |
| 137 | positive regulation of mitochondrial fission (GO:0090141) | 2.57440396 |
| 138 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.57351656 |
| 139 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.57244308 |
| 140 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.57244308 |
| 141 | ethanol metabolic process (GO:0006067) | 2.57012605 |
| 142 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.55979713 |
| 143 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.55979713 |
| 144 | cellular glucuronidation (GO:0052695) | 2.55619649 |
| 145 | negative regulation of cholesterol transport (GO:0032375) | 2.55501826 |
| 146 | negative regulation of sterol transport (GO:0032372) | 2.55501826 |
| 147 | regulation of memory T cell differentiation (GO:0043380) | 2.55428421 |
| 148 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.55308444 |
| 149 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.54073862 |
| 150 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.53984368 |
| 151 | regulation of female gonad development (GO:2000194) | 2.53181622 |
| 152 | somite rostral/caudal axis specification (GO:0032525) | 2.52565888 |
| 153 | regulation of cholesterol metabolic process (GO:0090181) | 2.52181646 |
| 154 | sperm motility (GO:0030317) | 2.51699946 |
| 155 | growth hormone receptor signaling pathway (GO:0060396) | 2.51421239 |
| 156 | central nervous system neuron axonogenesis (GO:0021955) | 2.50827945 |
| 157 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.50448909 |
| 158 | inositol phosphate catabolic process (GO:0071545) | 2.50028580 |
| 159 | ganglion development (GO:0061548) | 2.49830013 |
| 160 | activated T cell proliferation (GO:0050798) | 2.49035719 |
| 161 | regulation of humoral immune response (GO:0002920) | 2.48641214 |
| 162 | plasma lipoprotein particle organization (GO:0071827) | 2.47570434 |
| 163 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.46145340 |
| 164 | fibrinolysis (GO:0042730) | 2.45708653 |
| 165 | cellular response to vitamin D (GO:0071305) | 2.45681726 |
| 166 | detection of light stimulus involved in visual perception (GO:0050908) | 2.45632177 |
| 167 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.45632177 |
| 168 | coenzyme catabolic process (GO:0009109) | 2.43796089 |
| 169 | single strand break repair (GO:0000012) | 2.43514293 |
| 170 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42585211 |
| 171 | RNA destabilization (GO:0050779) | 2.42448344 |
| 172 | cell proliferation in forebrain (GO:0021846) | 2.41889386 |
| 173 | short-chain fatty acid metabolic process (GO:0046459) | 2.41076625 |
| 174 | regulation of collateral sprouting (GO:0048670) | 2.40724002 |
| 175 | positive regulation of lipid catabolic process (GO:0050996) | 2.40260761 |
| 176 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.39410466 |
| 177 | complement activation (GO:0006956) | 2.38961173 |
| 178 | glutamate metabolic process (GO:0006536) | 2.38953029 |
| 179 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.38728868 |
| 180 | complement activation, classical pathway (GO:0006958) | 2.38643142 |
| 181 | protein-lipid complex subunit organization (GO:0071825) | 2.38590403 |
| 182 | low-density lipoprotein particle remodeling (GO:0034374) | 2.37615771 |
| 183 | positive regulation of steroid metabolic process (GO:0045940) | 2.37443726 |
| 184 | benzene-containing compound metabolic process (GO:0042537) | 2.37186063 |
| 185 | fatty acid oxidation (GO:0019395) | 2.37147038 |
| 186 | 2-oxoglutarate metabolic process (GO:0006103) | 2.36154053 |
| 187 | homocysteine metabolic process (GO:0050667) | 2.34093922 |
| 188 | positive regulation of blood coagulation (GO:0030194) | 2.33855185 |
| 189 | positive regulation of hemostasis (GO:1900048) | 2.33855185 |
| 190 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.33283646 |
| 191 | lipid oxidation (GO:0034440) | 2.33193397 |
| 192 | lipoprotein metabolic process (GO:0042157) | 2.32869354 |
| 193 | negative regulation of protein activation cascade (GO:2000258) | 2.32793364 |
| 194 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.32388656 |
| 195 | regulation of cholesterol homeostasis (GO:2000188) | 2.32282589 |
| 196 | indolalkylamine metabolic process (GO:0006586) | 2.31808949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.46729314 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11711537 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57807760 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51313789 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.37191193 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31328089 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24031584 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.23411681 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17640606 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.15021657 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.05507459 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.95572114 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.90940351 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86961708 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.74667417 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57805067 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55887630 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33825751 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26762763 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 2.25877235 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21590574 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.18243912 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17711008 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17315039 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16407422 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12748442 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11337480 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.08806289 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 2.08486195 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.04076251 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03512305 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00165302 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98193758 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.96244816 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90255103 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89717550 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.89489194 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87191605 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86641808 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86198792 |
| 41 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84292026 |
| 42 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.84292026 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83302503 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83207688 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82638703 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.82542246 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.81050430 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.78442596 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75827066 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75159839 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73164922 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70106687 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.70008053 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.70008053 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68436164 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68265216 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64183585 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64090441 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62322743 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60129112 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59366229 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58963437 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55784840 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55603899 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55391561 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.54237669 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.53949809 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.53799565 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53090044 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51575185 |
| 71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50877515 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49653891 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49478191 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48375192 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47942245 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47432406 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46879605 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45132554 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43724675 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43235652 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42295264 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41117515 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40715933 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.38868324 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38494299 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36198942 |
| 87 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35550594 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31163511 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27681580 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26845155 |
| 91 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.26719598 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26338170 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25664602 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25307840 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25088081 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24067194 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23953643 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23696801 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22928108 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22386537 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20395992 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20395992 |
| 103 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20272909 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19298458 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18513284 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18209807 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17583247 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17036124 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16538655 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 1.15751114 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15645333 |
| 112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15644383 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15070620 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14694053 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14520629 |
| 116 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13891552 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13676902 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13654503 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13559762 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13033635 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12962905 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12880843 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12704213 |
| 124 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.12573104 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12533678 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11592342 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10416422 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09666065 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09614609 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09560133 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09458519 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09421618 |
| 133 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.09389361 |
| 134 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09068018 |
| 135 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08955900 |
| 136 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.07482849 |
| 137 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07383603 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06960383 |
| 139 | MYB_26560356_Chip-Seq_TH1_Human | 1.06644530 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06469377 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06236228 |
| 142 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06092551 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06053603 |
| 144 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05639011 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05217623 |
| 146 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05140829 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04182198 |
| 148 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04078244 |
| 149 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03766752 |
| 150 | TBL1_22424771_ChIP-Seq_293T_Human | 1.03212107 |
| 151 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03151386 |
| 152 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01681578 |
| 153 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01086393 |
| 154 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00924362 |
| 155 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00835976 |
| 156 | JUN_21703547_ChIP-Seq_K562_Human | 1.00353228 |
| 157 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99715421 |
| 158 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99621964 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99581608 |
| 160 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98630361 |
| 161 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98485503 |
| 162 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97466146 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97412059 |
| 164 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96675757 |
| 165 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96339590 |
| 166 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94424589 |
| 167 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94223198 |
| 168 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93240694 |
| 169 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93211309 |
| 170 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93171604 |
| 171 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90560489 |
| 172 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89871437 |
| 173 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88698049 |
| 174 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88439077 |
| 175 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88057706 |
| 176 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85148331 |
| 177 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84884546 |
| 178 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82260477 |
| 179 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81498047 |
| 180 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81200620 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80526847 |
| 182 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80418474 |
| 183 | MAF_26560356_Chip-Seq_TH1_Human | 0.80036635 |
| 184 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79844756 |
| 185 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79086767 |
| 186 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78416897 |
| 187 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78416756 |
| 188 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78181307 |
| 189 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77104067 |
| 190 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76545186 |
| 191 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75932373 |
| 192 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.75800557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.78604793 |
| 2 | MP0005360_urolithiasis | 4.37963689 |
| 3 | MP0003787_abnormal_imprinting | 4.22921718 |
| 4 | MP0005365_abnormal_bile_salt | 4.04237057 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.91978525 |
| 6 | MP0008877_abnormal_DNA_methylation | 3.41151650 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15501333 |
| 8 | MP0003252_abnormal_bile_duct | 3.06546960 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.91709140 |
| 10 | MP0008789_abnormal_olfactory_epithelium | 2.77822120 |
| 11 | MP0005499_abnormal_olfactory_system | 2.72438243 |
| 12 | MP0005394_taste/olfaction_phenotype | 2.72438243 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.70104883 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.54801936 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.49783804 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.41531500 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 2.39490987 |
| 18 | MP0003122_maternal_imprinting | 2.31320800 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.30868810 |
| 20 | MP0000427_abnormal_hair_cycle | 2.28298824 |
| 21 | MP0002653_abnormal_ependyma_morphology | 2.27998855 |
| 22 | MP0003121_genomic_imprinting | 2.26613169 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.14570917 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.10904500 |
| 25 | MP0005248_abnormal_Harderian_gland | 2.10714329 |
| 26 | MP0009840_abnormal_foam_cell | 2.07601611 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.99967477 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.97496218 |
| 29 | MP0003868_abnormal_feces_composition | 1.97146238 |
| 30 | MP0008057_abnormal_DNA_replication | 1.96474019 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.94478215 |
| 32 | MP0005187_abnormal_penis_morphology | 1.92848478 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.88929926 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.81005116 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.78325247 |
| 36 | MP0005253_abnormal_eye_physiology | 1.77288761 |
| 37 | MP0000778_abnormal_nervous_system | 1.76620477 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.73731099 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.71944245 |
| 40 | MP0002163_abnormal_gland_morphology | 1.71533032 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.70261742 |
| 42 | MP0005083_abnormal_biliary_tract | 1.66088007 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.65222213 |
| 44 | MP0000685_abnormal_immune_system | 1.59531942 |
| 45 | MP0001529_abnormal_vocalization | 1.59048955 |
| 46 | MP0003724_increased_susceptibility_to | 1.58604031 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.58098568 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.56843953 |
| 49 | MP0006054_spinal_hemorrhage | 1.56624291 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.54715847 |
| 51 | MP0000609_abnormal_liver_physiology | 1.52963216 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.52156662 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.51353542 |
| 54 | MP0001984_abnormal_olfaction | 1.50190334 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.46127695 |
| 56 | MP0000383_abnormal_hair_follicle | 1.45514455 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.45062444 |
| 58 | MP0003195_calcinosis | 1.42435577 |
| 59 | MP0005332_abnormal_amino_acid | 1.42253683 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.42063307 |
| 61 | MP0005671_abnormal_response_to | 1.41464789 |
| 62 | MP0002233_abnormal_nose_morphology | 1.40384732 |
| 63 | MP0004133_heterotaxia | 1.39949316 |
| 64 | MP0002928_abnormal_bile_duct | 1.39665824 |
| 65 | MP0005408_hypopigmentation | 1.37240119 |
| 66 | MP0002102_abnormal_ear_morphology | 1.36780663 |
| 67 | MP0002419_abnormal_innate_immunity | 1.34776999 |
| 68 | MP0002822_catalepsy | 1.32866552 |
| 69 | MP0003880_abnormal_central_pattern | 1.26455134 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.25395801 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25084754 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.24907020 |
| 73 | MP0001873_stomach_inflammation | 1.20365201 |
| 74 | MP0005387_immune_system_phenotype | 1.19799587 |
| 75 | MP0001790_abnormal_immune_system | 1.19799587 |
| 76 | MP0005410_abnormal_fertilization | 1.18563674 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 1.17211614 |
| 78 | MP0003279_aneurysm | 1.15450838 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.15008607 |
| 80 | MP0003690_abnormal_glial_cell | 1.14302769 |
| 81 | MP0002254_reproductive_system_inflammat | 1.13216025 |
| 82 | MP0002006_tumorigenesis | 1.13200658 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.12354739 |
| 84 | MP0009764_decreased_sensitivity_to | 1.12118755 |
| 85 | MP0005025_abnormal_response_to | 1.10679183 |
| 86 | MP0001486_abnormal_startle_reflex | 1.10559537 |
| 87 | MP0008995_early_reproductive_senescence | 1.09910561 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.09483279 |
| 89 | MP0009785_altered_susceptibility_to | 1.09196885 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.08255018 |
| 91 | MP0001270_distended_abdomen | 1.07497882 |
| 92 | MP0000647_abnormal_sebaceous_gland | 1.06075112 |
| 93 | MP0008469_abnormal_protein_level | 1.03686967 |
| 94 | MP0002396_abnormal_hematopoietic_system | 1.03583516 |
| 95 | MP0003436_decreased_susceptibility_to | 1.03312201 |
| 96 | MP0004134_abnormal_chest_morphology | 1.03213589 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.02533032 |
| 98 | MP0010678_abnormal_skin_adnexa | 1.02139461 |
| 99 | MP0000604_amyloidosis | 1.01315028 |
| 100 | MP0005310_abnormal_salivary_gland | 1.01298775 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 1.01232059 |
| 102 | MP0001853_heart_inflammation | 1.00505574 |
| 103 | MP0005195_abnormal_posterior_eye | 1.00109051 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.99972075 |
| 105 | MP0002557_abnormal_social/conspecific_i | 0.99452029 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.99055118 |
| 107 | MP0005000_abnormal_immune_tolerance | 0.98604512 |
| 108 | MP0002272_abnormal_nervous_system | 0.98162893 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.98080102 |
| 110 | MP0004742_abnormal_vestibular_system | 0.98063917 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.98044748 |
| 112 | MP0001879_abnormal_lymphatic_vessel | 0.97411077 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.95593798 |
| 114 | MP0002184_abnormal_innervation | 0.95303108 |
| 115 | MP0003303_peritoneal_inflammation | 0.94836632 |
| 116 | MP0001800_abnormal_humoral_immune | 0.94459023 |
| 117 | MP0001545_abnormal_hematopoietic_system | 0.93468981 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.93468981 |
| 119 | MP0005389_reproductive_system_phenotype | 0.93182989 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.92884439 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.92598172 |
| 122 | MP0005334_abnormal_fat_pad | 0.91749832 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.91154063 |
| 124 | MP0000371_diluted_coat_color | 0.90610441 |
| 125 | MP0000598_abnormal_liver_morphology | 0.90516918 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.90067016 |
| 127 | MP0006082_CNS_inflammation | 0.89281034 |
| 128 | MP0002723_abnormal_immune_serum | 0.88986145 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.88146350 |
| 130 | MP0005391_vision/eye_phenotype | 0.87879968 |
| 131 | MP0009763_increased_sensitivity_to | 0.87685149 |
| 132 | MP0004947_skin_inflammation | 0.87617307 |
| 133 | MP0004381_abnormal_hair_follicle | 0.87474053 |
| 134 | MP0008004_abnormal_stomach_pH | 0.86725382 |
| 135 | MP0004142_abnormal_muscle_tone | 0.86604214 |
| 136 | MP0009046_muscle_twitch | 0.86358103 |
| 137 | MP0001533_abnormal_skeleton_physiology | 0.86346099 |
| 138 | MP0002067_abnormal_sensory_capabilities | 0.86184659 |
| 139 | MP0003698_abnormal_male_reproductive | 0.86096924 |
| 140 | MP0004130_abnormal_muscle_cell | 0.85342115 |
| 141 | MP0002933_joint_inflammation | 0.84733845 |
| 142 | MP0001188_hyperpigmentation | 0.84184533 |
| 143 | MP0000920_abnormal_myelination | 0.82919449 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.82639300 |
| 145 | MP0002420_abnormal_adaptive_immunity | 0.82601246 |
| 146 | MP0000955_abnormal_spinal_cord | 0.82570039 |
| 147 | MP0002095_abnormal_skin_pigmentation | 0.82470917 |
| 148 | MP0003011_delayed_dark_adaptation | 0.81210006 |
| 149 | MP0003075_altered_response_to | 0.80695955 |
| 150 | MP0002090_abnormal_vision | 0.80574086 |
| 151 | MP0001819_abnormal_immune_cell | 0.80369055 |
| 152 | MP0001944_abnormal_pancreas_morphology | 0.79618675 |
| 153 | MP0001501_abnormal_sleep_pattern | 0.79457635 |
| 154 | MP0002882_abnormal_neuron_morphology | 0.79359219 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.77430470 |
| 156 | MP0000015_abnormal_ear_pigmentation | 0.76619443 |
| 157 | MP0001919_abnormal_reproductive_system | 0.76347290 |
| 158 | MP0004885_abnormal_endolymph | 0.76039886 |
| 159 | MP0002693_abnormal_pancreas_physiology | 0.75638864 |
| 160 | MP0001851_eye_inflammation | 0.74598380 |
| 161 | MP0003943_abnormal_hepatobiliary_system | 0.74526355 |
| 162 | MP0002572_abnormal_emotion/affect_behav | 0.74142193 |
| 163 | MP0002009_preneoplasia | 0.72810188 |
| 164 | MP0002136_abnormal_kidney_physiology | 0.72728557 |
| 165 | MP0003763_abnormal_thymus_physiology | 0.72317556 |
| 166 | MP0000372_irregular_coat_pigmentation | 0.72073638 |
| 167 | MP0005551_abnormal_eye_electrophysiolog | 0.71833919 |
| 168 | MP0002160_abnormal_reproductive_system | 0.71324615 |
| 169 | MP0005386_behavior/neurological_phenoty | 0.70295130 |
| 170 | MP0004924_abnormal_behavior | 0.70295130 |
| 171 | MP0004811_abnormal_neuron_physiology | 0.69977270 |
| 172 | MP0001929_abnormal_gametogenesis | 0.68251268 |
| 173 | MP0000049_abnormal_middle_ear | 0.66832633 |
| 174 | MP0001542_abnormal_bone_strength | 0.66432179 |
| 175 | MP0000639_abnormal_adrenal_gland | 0.66339672 |
| 176 | MP0003938_abnormal_ear_development | 0.65576450 |
| 177 | MP0001293_anophthalmia | 0.63437746 |
| 178 | MP0003632_abnormal_nervous_system | 0.62800953 |
| 179 | MP0001756_abnormal_urination | 0.62642355 |
| 180 | MP0003119_abnormal_digestive_system | 0.61456937 |
| 181 | MP0003937_abnormal_limbs/digits/tail_de | 0.60746230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.79370566 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.56352729 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.51550710 |
| 4 | Chronic hepatic failure (HP:0100626) | 4.12882641 |
| 5 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01103400 |
| 6 | Xanthomatosis (HP:0000991) | 3.98425469 |
| 7 | Pancreatic cysts (HP:0001737) | 3.95091458 |
| 8 | Complement deficiency (HP:0004431) | 3.93806833 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.86319765 |
| 10 | Nephronophthisis (HP:0000090) | 3.65308563 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 3.64765220 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.59495377 |
| 13 | Molar tooth sign on MRI (HP:0002419) | 3.58724634 |
| 14 | Abnormality of midbrain morphology (HP:0002418) | 3.58724634 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57669166 |
| 16 | True hermaphroditism (HP:0010459) | 3.56769993 |
| 17 | Tubulointerstitial nephritis (HP:0001970) | 3.47064926 |
| 18 | Abnormality of the renal medulla (HP:0100957) | 3.34165667 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.20615517 |
| 20 | Gingival bleeding (HP:0000225) | 3.20535068 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.14142842 |
| 22 | Joint hemorrhage (HP:0005261) | 3.13807708 |
| 23 | Gait imbalance (HP:0002141) | 3.11503436 |
| 24 | Congenital primary aphakia (HP:0007707) | 3.10011211 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.00512531 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 2.96270006 |
| 27 | Intestinal atresia (HP:0011100) | 2.96192086 |
| 28 | Nephrogenic diabetes insipidus (HP:0009806) | 2.91946986 |
| 29 | Abnormality of complement system (HP:0005339) | 2.91631442 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.89745052 |
| 31 | Tubular atrophy (HP:0000092) | 2.84584656 |
| 32 | Hyperventilation (HP:0002883) | 2.82672700 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.79834748 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.78728430 |
| 35 | Hepatoblastoma (HP:0002884) | 2.77178901 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 2.76505433 |
| 37 | Menorrhagia (HP:0000132) | 2.72489880 |
| 38 | Mitral stenosis (HP:0001718) | 2.72450960 |
| 39 | Epidermoid cyst (HP:0200040) | 2.70886156 |
| 40 | Hypoglycemic seizures (HP:0002173) | 2.69062987 |
| 41 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.68433621 |
| 42 | Abnormality of macular pigmentation (HP:0008002) | 2.67949701 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.67900122 |
| 44 | Epistaxis (HP:0000421) | 2.66785617 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.63442994 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.61477890 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.60780485 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60780485 |
| 49 | Drooling (HP:0002307) | 2.60149794 |
| 50 | Fat malabsorption (HP:0002630) | 2.59903456 |
| 51 | Poor coordination (HP:0002370) | 2.59521199 |
| 52 | Glomerulonephritis (HP:0000099) | 2.59115641 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.57407464 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53862942 |
| 55 | Postaxial foot polydactyly (HP:0001830) | 2.53432813 |
| 56 | Pulmonary embolism (HP:0002204) | 2.52983139 |
| 57 | Papillary thyroid carcinoma (HP:0002895) | 2.50049344 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.49983255 |
| 59 | Excessive salivation (HP:0003781) | 2.48621231 |
| 60 | Abnormal pancreas size (HP:0012094) | 2.48597911 |
| 61 | Protuberant abdomen (HP:0001538) | 2.46374000 |
| 62 | Hip dysplasia (HP:0001385) | 2.44671641 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44588605 |
| 64 | Genital tract atresia (HP:0001827) | 2.44497461 |
| 65 | Ketosis (HP:0001946) | 2.43456862 |
| 66 | Hematochezia (HP:0002573) | 2.39830529 |
| 67 | Absent speech (HP:0001344) | 2.38042156 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38029121 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38029121 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38029121 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.37947136 |
| 72 | Abnormal platelet function (HP:0011869) | 2.37947136 |
| 73 | Renal cortical cysts (HP:0000803) | 2.37752389 |
| 74 | Thin bony cortex (HP:0002753) | 2.36656585 |
| 75 | Amyloidosis (HP:0011034) | 2.36351873 |
| 76 | Myocardial infarction (HP:0001658) | 2.35974477 |
| 77 | Tubulointerstitial abnormality (HP:0001969) | 2.34138874 |
| 78 | Vaginal atresia (HP:0000148) | 2.33200573 |
| 79 | Esophageal varix (HP:0002040) | 2.32972865 |
| 80 | Adrenal hypoplasia (HP:0000835) | 2.32427249 |
| 81 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31923922 |
| 82 | Attenuation of retinal blood vessels (HP:0007843) | 2.31297647 |
| 83 | Absent/shortened dynein arms (HP:0200106) | 2.31246593 |
| 84 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.31246593 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.29578550 |
| 86 | Hypercholesterolemia (HP:0003124) | 2.28745091 |
| 87 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28283197 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.27731786 |
| 89 | Hypolipoproteinemia (HP:0010981) | 2.25030409 |
| 90 | Purpura (HP:0000979) | 2.22546036 |
| 91 | Thrombophlebitis (HP:0004418) | 2.21227694 |
| 92 | Enlarged kidneys (HP:0000105) | 2.21147389 |
| 93 | Symptomatic seizures (HP:0011145) | 2.20969214 |
| 94 | Cystic liver disease (HP:0006706) | 2.19169547 |
| 95 | Widely spaced teeth (HP:0000687) | 2.18559737 |
| 96 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17855095 |
| 97 | Postaxial hand polydactyly (HP:0001162) | 2.17551727 |
| 98 | Congenital hepatic fibrosis (HP:0002612) | 2.17434635 |
| 99 | Abnormal ciliary motility (HP:0012262) | 2.17067363 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.16771073 |
| 101 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.15492706 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 2.15327378 |
| 103 | Thyroid carcinoma (HP:0002890) | 2.15278652 |
| 104 | Progressive inability to walk (HP:0002505) | 2.12675959 |
| 105 | Growth hormone deficiency (HP:0000824) | 2.12366524 |
| 106 | Periodontitis (HP:0000704) | 2.12228502 |
| 107 | Osteomalacia (HP:0002749) | 2.11328845 |
| 108 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.10597517 |
| 109 | Hypoalphalipoproteinemia (HP:0003233) | 2.10004192 |
| 110 | Macroorchidism (HP:0000053) | 2.09778310 |
| 111 | Gaze-evoked nystagmus (HP:0000640) | 2.07587159 |
| 112 | Hepatocellular carcinoma (HP:0001402) | 2.06276238 |
| 113 | Inability to walk (HP:0002540) | 2.05970705 |
| 114 | Retinitis pigmentosa (HP:0000510) | 2.04705220 |
| 115 | Myositis (HP:0100614) | 2.04454154 |
| 116 | Anencephaly (HP:0002323) | 2.04393301 |
| 117 | Congenital stationary night blindness (HP:0007642) | 2.03296336 |
| 118 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02289699 |
| 119 | Thyroiditis (HP:0100646) | 2.00776826 |
| 120 | Median cleft lip (HP:0000161) | 2.00527377 |
| 121 | Vitreoretinal degeneration (HP:0000655) | 1.99972035 |
| 122 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.99960243 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.99960243 |
| 124 | Microcytic anemia (HP:0001935) | 1.97822906 |
| 125 | Pendular nystagmus (HP:0012043) | 1.97447863 |
| 126 | Chronic otitis media (HP:0000389) | 1.97159794 |
| 127 | Abnormal biliary tract physiology (HP:0012439) | 1.96784890 |
| 128 | Bile duct proliferation (HP:0001408) | 1.96784890 |
| 129 | Acanthocytosis (HP:0001927) | 1.96175674 |
| 130 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94270864 |
| 131 | Lissencephaly (HP:0001339) | 1.92344895 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.91980490 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.91980490 |
| 134 | Broad-based gait (HP:0002136) | 1.91707126 |
| 135 | Pachygyria (HP:0001302) | 1.89563209 |
| 136 | Type II lissencephaly (HP:0007260) | 1.89091369 |
| 137 | Ketoacidosis (HP:0001993) | 1.88993606 |
| 138 | Bifid tongue (HP:0010297) | 1.88989766 |
| 139 | Neoplasm of the adrenal cortex (HP:0100641) | 1.88892777 |
| 140 | Severe visual impairment (HP:0001141) | 1.88210001 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.87702826 |
| 142 | Pancreatitis (HP:0001733) | 1.87466647 |
| 143 | Narrow forehead (HP:0000341) | 1.86709559 |
| 144 | Specific learning disability (HP:0001328) | 1.86699050 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.86539410 |
| 146 | Abnormality of proline metabolism (HP:0010907) | 1.86539410 |
| 147 | Abdominal distention (HP:0003270) | 1.86304025 |
| 148 | Labial hypoplasia (HP:0000066) | 1.85669234 |
| 149 | Optic nerve hypoplasia (HP:0000609) | 1.85100528 |
| 150 | Occipital encephalocele (HP:0002085) | 1.85059183 |
| 151 | Volvulus (HP:0002580) | 1.84783629 |
| 152 | Hyperammonemia (HP:0001987) | 1.84657077 |
| 153 | Short foot (HP:0001773) | 1.83850033 |
| 154 | Nephritis (HP:0000123) | 1.82682584 |
| 155 | Vacuolated lymphocytes (HP:0001922) | 1.82669820 |
| 156 | Steatorrhea (HP:0002570) | 1.81577003 |
| 157 | Arterial thrombosis (HP:0004420) | 1.81561130 |
| 158 | Decreased central vision (HP:0007663) | 1.81319051 |
| 159 | Genetic anticipation (HP:0003743) | 1.80967692 |
| 160 | Metaphyseal dysplasia (HP:0100255) | 1.79444270 |
| 161 | Abnormality of methionine metabolism (HP:0010901) | 1.78472644 |
| 162 | Growth hormone excess (HP:0000845) | 1.77413442 |
| 163 | Papilledema (HP:0001085) | 1.76870106 |
| 164 | Limb dystonia (HP:0002451) | 1.76677929 |
| 165 | IgM deficiency (HP:0002850) | 1.75936628 |
| 166 | Spondylolisthesis (HP:0003302) | 1.75752877 |
| 167 | Astigmatism (HP:0000483) | 1.74967529 |
| 168 | Polydipsia (HP:0001959) | 1.74002762 |
| 169 | Abnormal drinking behavior (HP:0030082) | 1.74002762 |
| 170 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73968376 |
| 171 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73968376 |
| 172 | Interstitial pulmonary disease (HP:0006530) | 1.73696463 |
| 173 | Agitation (HP:0000713) | 1.73618342 |
| 174 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.73575234 |
| 175 | Curly hair (HP:0002212) | 1.72461256 |
| 176 | Male pseudohermaphroditism (HP:0000037) | 1.72346496 |
| 177 | Blue irides (HP:0000635) | 1.72291816 |
| 178 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71455378 |
| 179 | Broad foot (HP:0001769) | 1.71287049 |
| 180 | Anosmia (HP:0000458) | 1.70119294 |
| 181 | Elevated alkaline phosphatase (HP:0003155) | 1.70084607 |
| 182 | Polyphagia (HP:0002591) | 1.69919129 |
| 183 | Oligodactyly (hands) (HP:0001180) | 1.69054411 |
| 184 | Hypoplasia of the thymus (HP:0000778) | 1.68904338 |
| 185 | Dyskinesia (HP:0100660) | 1.68715148 |
| 186 | Increased corneal curvature (HP:0100692) | 1.67098319 |
| 187 | Keratoconus (HP:0000563) | 1.67098319 |
| 188 | Retinal atrophy (HP:0001105) | 1.65811887 |
| 189 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.65541057 |
| 190 | Recurrent viral infections (HP:0004429) | 1.65056552 |
| 191 | Abnormality of purine metabolism (HP:0004352) | 1.64432339 |
| 192 | Gastrointestinal infarctions (HP:0005244) | 1.64428385 |
| 193 | Cardiomegaly (HP:0001640) | 1.63915677 |
| 194 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.63765250 |
| 195 | Inflammation of the large intestine (HP:0002037) | 1.63166497 |
| 196 | Hemorrhage of the eye (HP:0011885) | 1.62474201 |
| 197 | Eczematoid dermatitis (HP:0000976) | 1.62340258 |
| 198 | Increased CSF protein (HP:0002922) | 1.60584270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.76926538 |
| 2 | TAOK3 | 2.97340185 |
| 3 | BRSK2 | 2.92481110 |
| 4 | MAP3K4 | 2.92069739 |
| 5 | FGFR4 | 2.88293347 |
| 6 | TGFBR2 | 2.86485644 |
| 7 | PINK1 | 2.69354059 |
| 8 | MAP4K2 | 2.60626201 |
| 9 | STK38L | 2.50018228 |
| 10 | ERN1 | 2.47290261 |
| 11 | CASK | 2.42722370 |
| 12 | MAP2K7 | 2.29047962 |
| 13 | SIK1 | 2.24910181 |
| 14 | FGFR2 | 2.22519845 |
| 15 | FGFR3 | 2.19096047 |
| 16 | WNK3 | 2.13328564 |
| 17 | MAP4K1 | 2.10260388 |
| 18 | PKN2 | 2.10030607 |
| 19 | BRD4 | 2.06071485 |
| 20 | EPHB1 | 2.03267079 |
| 21 | PTK6 | 1.95605755 |
| 22 | ACVR1B | 1.89816381 |
| 23 | CAMKK2 | 1.85007973 |
| 24 | TIE1 | 1.75965771 |
| 25 | DYRK3 | 1.72894183 |
| 26 | BCR | 1.71435479 |
| 27 | KIT | 1.68793734 |
| 28 | MAPKAPK5 | 1.66629396 |
| 29 | EPHA3 | 1.63949366 |
| 30 | TYK2 | 1.63805379 |
| 31 | JAK1 | 1.61658410 |
| 32 | ITK | 1.61614649 |
| 33 | MAP2K4 | 1.59644838 |
| 34 | JAK3 | 1.52754958 |
| 35 | PAK3 | 1.51795242 |
| 36 | MAPK13 | 1.51565533 |
| 37 | MST1R | 1.49980226 |
| 38 | TRIB3 | 1.48915585 |
| 39 | EEF2K | 1.48559618 |
| 40 | BMPR1B | 1.47953068 |
| 41 | MAP3K13 | 1.45954483 |
| 42 | BTK | 1.43358121 |
| 43 | TEC | 1.40891425 |
| 44 | NEK9 | 1.39860466 |
| 45 | TBK1 | 1.38221683 |
| 46 | ZAP70 | 1.35675572 |
| 47 | TGFBR1 | 1.35656234 |
| 48 | TRIM28 | 1.32750010 |
| 49 | AKT3 | 1.29124721 |
| 50 | FRK | 1.27896260 |
| 51 | HIPK2 | 1.27714443 |
| 52 | TXK | 1.26993030 |
| 53 | RIPK4 | 1.25680669 |
| 54 | RET | 1.22927492 |
| 55 | ADRBK2 | 1.22649932 |
| 56 | MAPK15 | 1.21733922 |
| 57 | CSNK1G2 | 1.19941498 |
| 58 | CDK19 | 1.19548114 |
| 59 | MARK3 | 1.17213056 |
| 60 | TRPM7 | 1.15914684 |
| 61 | GRK1 | 1.15261458 |
| 62 | TAOK1 | 1.14789844 |
| 63 | CAMK1G | 1.11754516 |
| 64 | DYRK2 | 1.11549013 |
| 65 | MAP3K14 | 1.11165542 |
| 66 | JAK2 | 1.10284790 |
| 67 | FLT3 | 1.09692813 |
| 68 | MAP3K7 | 1.08431312 |
| 69 | IKBKE | 1.07740184 |
| 70 | PLK2 | 1.07589521 |
| 71 | CAMK1D | 1.05579509 |
| 72 | CSNK1G3 | 1.04539478 |
| 73 | DYRK1A | 1.02568663 |
| 74 | TNIK | 1.00690519 |
| 75 | MARK1 | 0.99301461 |
| 76 | MARK2 | 0.99281389 |
| 77 | BLK | 0.98112989 |
| 78 | RIPK1 | 0.96568379 |
| 79 | MKNK2 | 0.95575690 |
| 80 | PDGFRB | 0.95194909 |
| 81 | CSF1R | 0.93910407 |
| 82 | SGK3 | 0.92907429 |
| 83 | PRKCH | 0.91301805 |
| 84 | ERBB3 | 0.91092009 |
| 85 | STK38 | 0.90689575 |
| 86 | LATS1 | 0.90161131 |
| 87 | LRRK2 | 0.89880361 |
| 88 | PRKCE | 0.89052089 |
| 89 | CSNK1A1L | 0.87964715 |
| 90 | PDGFRA | 0.87178455 |
| 91 | STK11 | 0.85974854 |
| 92 | NLK | 0.85922223 |
| 93 | SYK | 0.84088144 |
| 94 | LCK | 0.83050314 |
| 95 | HCK | 0.81959062 |
| 96 | STK3 | 0.81243722 |
| 97 | BCKDK | 0.81151070 |
| 98 | PDK1 | 0.81055872 |
| 99 | PLK4 | 0.80236152 |
| 100 | ZAK | 0.79468287 |
| 101 | CSK | 0.79270467 |
| 102 | NTRK3 | 0.79252597 |
| 103 | DAPK2 | 0.77281782 |
| 104 | DYRK1B | 0.75451526 |
| 105 | MATK | 0.75290121 |
| 106 | MST4 | 0.74183517 |
| 107 | CDK6 | 0.72083474 |
| 108 | ERBB2 | 0.71664407 |
| 109 | DMPK | 0.69440925 |
| 110 | WNK1 | 0.68220633 |
| 111 | PRKCQ | 0.67844396 |
| 112 | IGF1R | 0.67749787 |
| 113 | MKNK1 | 0.67378339 |
| 114 | LYN | 0.65973475 |
| 115 | STK10 | 0.65743269 |
| 116 | MAP2K3 | 0.65570766 |
| 117 | STK39 | 0.65259906 |
| 118 | MAP3K5 | 0.64841493 |
| 119 | PDPK1 | 0.63598133 |
| 120 | MAP3K10 | 0.62684718 |
| 121 | MAPK7 | 0.62082771 |
| 122 | SIK3 | 0.61400391 |
| 123 | IRAK4 | 0.59994118 |
| 124 | WNK4 | 0.59953391 |
| 125 | SGK494 | 0.58839861 |
| 126 | SGK223 | 0.58839861 |
| 127 | MINK1 | 0.56782848 |
| 128 | CSNK1D | 0.56279007 |
| 129 | FES | 0.56264567 |
| 130 | TNK2 | 0.55290976 |
| 131 | KDR | 0.55240299 |
| 132 | FER | 0.53870831 |
| 133 | IRAK1 | 0.53867613 |
| 134 | OXSR1 | 0.53661571 |
| 135 | YES1 | 0.53354023 |
| 136 | PTK2B | 0.53302480 |
| 137 | MAP2K2 | 0.53140620 |
| 138 | PRKD1 | 0.51435842 |
| 139 | SCYL2 | 0.50728201 |
| 140 | MAPK4 | 0.49858671 |
| 141 | SGK2 | 0.49305096 |
| 142 | FGFR1 | 0.48828167 |
| 143 | GSK3A | 0.47860208 |
| 144 | NUAK1 | 0.47449173 |
| 145 | PRKCG | 0.45971116 |
| 146 | STK24 | 0.45305435 |
| 147 | CSNK1G1 | 0.45304863 |
| 148 | FYN | 0.45067842 |
| 149 | BMPR2 | 0.44867951 |
| 150 | MAP3K2 | 0.43980444 |
| 151 | EGFR | 0.43800367 |
| 152 | IRAK3 | 0.43643399 |
| 153 | PRKCZ | 0.42240820 |
| 154 | PRKG1 | 0.42223608 |
| 155 | MAP3K1 | 0.42106415 |
| 156 | RPS6KA2 | 0.41757722 |
| 157 | IKBKB | 0.41371627 |
| 158 | ADRBK1 | 0.41320151 |
| 159 | PRKAA2 | 0.41047131 |
| 160 | MAP3K6 | 0.40472389 |
| 161 | SGK1 | 0.39197716 |
| 162 | EIF2AK3 | 0.38966454 |
| 163 | CDK5 | 0.38815815 |
| 164 | CAMK4 | 0.35428848 |
| 165 | PIK3CA | 0.35187191 |
| 166 | KSR1 | 0.35057998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.98744296 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46926312 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65772436 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55206397 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.51718550 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44407105 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20933423 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.14201327 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14194558 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09487568 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01679517 |
| 12 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.94156665 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.92972018 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90782984 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88103084 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80260056 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.77078111 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64853905 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.61943436 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.59210463 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57546639 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.57277072 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.54681735 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52177551 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49532804 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49302985 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.42188134 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41123576 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39864485 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.37862390 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.36410557 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35760488 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.35033819 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.34723415 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33016482 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32485698 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31679474 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28885802 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.28522314 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25788360 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.25751717 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25499178 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22038161 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21060526 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20712023 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19477634 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18393306 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17220784 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16193043 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.15829369 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15823969 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13672661 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.11114960 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10930960 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 1.09860673 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.08355775 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07184005 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06492506 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06175700 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05806232 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04694542 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04374449 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00481235 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99459804 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98163327 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95850891 |
| 67 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.94419472 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90982107 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.85820042 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85315790 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84382522 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.83891318 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83219136 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82619923 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81235156 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78313825 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76967225 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.75949371 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74831209 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73455245 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73125025 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72305731 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.70540918 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70361666 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68312921 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67738275 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.67235840 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.66327845 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65849234 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65289842 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64636054 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64303421 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63879013 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.63039120 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.62690122 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61653566 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.61440421 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60305997 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58818917 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58404267 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57932479 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57645692 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56684488 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.56453491 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.56333929 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56305219 |
| 107 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56303470 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55633854 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54614317 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52577050 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52254565 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51888161 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50935562 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49696879 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49178346 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49093522 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48985901 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48643649 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47534418 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46740110 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46028133 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44493799 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44291566 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44215860 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43568946 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43156830 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43009474 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42681531 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42110726 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41389908 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41324960 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40875392 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40837765 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.39874313 |
| 135 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39847047 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39413415 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39399648 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39319473 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39245648 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38784073 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38767567 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38463143 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37947397 |
| 144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37677750 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37663794 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37525043 |
| 147 | Gap junction_Homo sapiens_hsa04540 | 0.37468375 |
| 148 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37276635 |
| 149 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36392410 |
| 150 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36216688 |
| 151 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36092658 |
| 152 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36066156 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.35748312 |
| 154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34587553 |
| 155 | Amoebiasis_Homo sapiens_hsa05146 | 0.33611143 |
| 156 | Measles_Homo sapiens_hsa05162 | 0.33105770 |
| 157 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31757223 |
| 158 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31683894 |
| 159 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30936336 |
| 160 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30816634 |
| 161 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30659922 |
| 162 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29839558 |
| 163 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29350309 |
| 164 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29194157 |
| 165 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28780587 |

